Cargando…
The therapeutic potential of targeting tryptophan catabolism in cancer
Based on its effects on both tumour cell intrinsic malignant properties as well as anti-tumour immune responses, tryptophan catabolism has emerged as an important metabolic regulator of cancer progression. Three enzymes, indoleamine-2,3-dioxygenase 1 and 2 (IDO1/2) and tryptophan-2,3-dioxygenase (TD...
Autores principales: | Opitz, Christiane A., Somarribas Patterson, Luis F., Mohapatra, Soumya R., Dewi, Dyah L., Sadik, Ahmed, Platten, Michael, Trump, Saskia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6964670/ https://www.ncbi.nlm.nih.gov/pubmed/31819194 http://dx.doi.org/10.1038/s41416-019-0664-6 |
Ejemplares similares
-
Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation
por: Adam, Isabell, et al.
Publicado: (2018) -
Hypoxia Routes Tryptophan Homeostasis Towards Increased Tryptamine Production
por: Mohapatra, Soumya R., et al.
Publicado: (2021) -
Hypoxia Inducible Factor 1α Inhibits the Expression of Immunosuppressive Tryptophan-2,3-Dioxygenase in Glioblastoma
por: Mohapatra, Soumya R., et al.
Publicado: (2019) -
Tryptophan Catabolism and Inflammation: A Novel Therapeutic Target For Aortic Diseases
por: Ramprasath, Tharmarajan, et al.
Publicado: (2021) -
Constitutive Expression of the Immunosuppressive Tryptophan Dioxygenase TDO2 in Glioblastoma Is Driven by the Transcription Factor C/EBPβ
por: Kudo, Takumi, et al.
Publicado: (2020)